Revolution Medicines, Inc. Share Price
RVMDRevolution Medicines, Inc. Stock Performance
Open $118.36 | Prev. Close $118.63 | Circuit Range N/A |
Day Range $116.57 - $120.40 | Year Range $29.17 - $124.49 | Volume 1,94,411 |
Average Traded $118.49 |
Revolution Medicines, Inc. Share Price Chart
About Revolution Medicines, Inc.
Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors to suppress cooperating targets and pathways that sustain RAS-addicted cancers. Its RAS(ON) inhibitors include daraxonrasib (RMC-6236), elironrasib G12C (RMC-6291), and zoldonrasib G12D (RMC-9805), which are in phase 1 clinical trial; and development candidates comprise RMC-5127 (G12V), RMC-0708 (Q61H), and RMC-8839 (G13C). The company's RAS companion inhibitors include RMC-4630 that is in phase 2 clinical trial; RMC-5552, a selective inhibitor of mTORC1 signaling in tumors, which is in phase 1 clinical trial; and RMC-5845 that targets SOS1. Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.
Revolution Medicines, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
21-Jan-26 | $115.50 | $117.53 | +1.15% |
20-Jan-26 | $118.45 | $116.19 | -3.43% |
16-Jan-26 | $124.45 | $120.32 | -2.42% |
15-Jan-26 | $120.85 | $123.31 | +1.88% |
14-Jan-26 | $119.22 | $121.03 | +0.95% |
13-Jan-26 | $117.89 | $119.90 | +2.33% |
12-Jan-26 | $116.30 | $117.17 | -1.47% |
FAQs on Revolution Medicines, Inc. Share Price
Can I buy Revolution Medicines, Inc. shares in India?
What is the share price of Revolution Medicines, Inc.?
What is the 5 year returns of Revolution Medicines, Inc.?
What are the high & low stock price of Revolution Medicines, Inc. today?
What is the 52-week high and low of Revolution Medicines, Inc. stock?